ONO 8130
Latest Information Update: 25 May 2010
At a glance
- Originator Ono Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pollakisuria; Urination disorders
Most Recent Events
- 20 May 2003 Preclinical trials in Pollakisuria in Japan (PO)
- 20 May 2003 Preclinical trials in Pollakisuria in USA (PO)
- 20 May 2003 Preclinical trials in Urination disorders in Japan (PO)